Infinium Pharmachem Ltd

NSE: INFINIUM · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹315.00
Market cap: ₹438.4 Cr
Revenue (annual): ₹189.6 Cr
Net profit (annual): ₹12.15 Cr
P/E (TTM): 36.1×Sector 47.4×
Promoter holding: 64.91%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Credit Rating 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 Sep 2026 11:49 IST NSE

Credit Rating

Infinium Pharmachem Credit Rating

ICRA assigned a new [ICRA]BBB (Stable) rating to Infinium Pharmachem's ₹52.20 Crore credit facilities. The assignment covers cash credit, term loans, and unallocated limits from ICICI Bank and SBI.

Read the filing ↗